Evidence map›Paper›PMID 19805360›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2009

The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development.

Katja S Grossmann, Hagen Wende, Florian E Paul, Cyril Cheret, Alistair N Garratt, Sandra Zurborg, Konstantin Feinberg, Daniel Besser, Herbert Schulz, Elior Peles and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. eNeuro · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Peripheral Nerve Development and the Pathogenesis of Peripheral Neuropathy: the Sorting Point.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  9. Myelin Biology.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  10. SHP2 regulates the development of intestinal epithelium by modifying OSTERIXFASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Loss of Shp2 Rescues BDNF/TrkB Signaling and Contributes to Improved Retinal Ganglion Cell Neuroprotection.Molecular therapy : the journal of the American Society of Gene Therapy · 2019
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 4 countries.

Katja S GrossmannNeuroscience Department, Department of Cancer Research, Department of Cardiovascular Research, Max-Delbrück-Centrum for Molecular Medicine, Robert-Rössle-Strasse 10, Berlin, Germany.
Hagen Wende
Florian E Paul
Cyril Cheret
Alistair N Garratt
Sandra Zurborg
Konstantin Feinberg
Daniel Besser
Herbert Schulz
Elior Peles
Matthias Selbach
Walter Birchmeier
Carmen Birchmeier
Institute of Cancer Research · CAMax Delbrück Center · DEWeizmann Institute of Science · ILEuropean Molecular Biology Laboratory · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nonreceptor tyrosine phosphatase Shp2 (PTPN11) has been implicated in tyrosine kinase, cytokine, and integrin receptor signaling. We show here that conditional mutation of Shp2 in neural crest cells and in myelinating Schwann cells resulted in deficits in glial development that are remarkably similar to those observed in mice mutant for Neuregulin-1 (Nrg1) or the Nrg1 receptors, ErbB2 and ErbB3. In cultured Shp2 mutant Schwann cells, Nrg1-evoked cellular responses like proliferation and migration were virtually abolished, and Nrg1-dependent intracellular signaling was altered. Pharmacological inhibition of Src family kinases mimicked all cellular and biochemical effects of the Shp2 mutation, implicating Src as a primary Shp2 target during Nrg1 signaling. Together, our genetic and biochemical analyses demonstrate that Shp2 is an essential component in the transduction of Nrg1/ErbB signals.

Indexed as

Signal TransductionAnimalsErbB ReceptorsFluorescent Antibody TechniqueMiceNeural CrestNeuregulin-1Protein Tyrosine Phosphatase, Non-Receptor Type 11Schwann CellsErbB ReceptorsNeuregulin-1Protein Tyrosine Phosphatase, Non-Receptor Type 11

Identifiers

PMID19805360
PMCPMC2742405
OpenAlexW2030860399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.